Omeros | OMER - Cost Of Sales


Omeros reported $33.16M in Cost of Sales for its fiscal quarter ending in June of 2024.





Cost Of Sales Change Date
Adma Biologics USD 58.64M 3.88M Sep/2025
Alnylam Pharmaceuticals USD 267.72M 67.57M Dec/2025
BioMarin Pharmaceutical USD 161.56M 16.62M Dec/2025
Cytokinetics USD 99.23M 13.32M Sep/2025
Gilead Sciences USD 1.62B 50M Dec/2025
Heron Therapeutics USD 9.46M 1.61M Sep/2024
Insmed USD 46.16M 15.25M Dec/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
MacroGenics USD 44.3M 5.4M Sep/2025
Omeros USD 33.16M 18.52M Jun/2024
Pacira USD 54.62M 6.02M Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
Rockwell Medical USD 21.28M 1.67M Jun/2024
Sangamo BioSciences 2.42M 1.11M Jun/2024
Sarepta Therapeutics USD 399.38M 247.93M Dec/2025
United Therapeutics USD 474.7M 373.8M Dec/2025
Vertex Pharmaceuticals USD 466M 51.2M Dec/2025
Xoma 116K 112.7K Jun/2024